76 related articles for article (PubMed ID: 17505477)
1. Expression of mutated huntingtin fragment in the putamen is sufficient to produce abnormal movement in non-human primates.
Palfi S; Brouillet E; Jarraya B; Bloch J; Jan C; Shin M; Condé F; Li XJ; Aebischer P; Hantraye P; Déglon N
Mol Ther; 2007 Aug; 15(8):1444-51. PubMed ID: 17505477
[TBL] [Abstract][Full Text] [Related]
2. Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated huntingtin.
Benchoua A; Trioulier Y; Zala D; Gaillard MC; Lefort N; Dufour N; Saudou F; Elalouf JM; Hirsch E; Hantraye P; Déglon N; Brouillet E
Mol Biol Cell; 2006 Apr; 17(4):1652-63. PubMed ID: 16452635
[TBL] [Abstract][Full Text] [Related]
3. Progressive and selective striatal degeneration in primary neuronal cultures using lentiviral vector coding for a mutant huntingtin fragment.
Zala D; Benchoua A; Brouillet E; Perrin V; Gaillard MC; Zurn AD; Aebischer P; Déglon N
Neurobiol Dis; 2005 Dec; 20(3):785-98. PubMed ID: 16006135
[TBL] [Abstract][Full Text] [Related]
4. Early and reversible neuropathology induced by tetracycline-regulated lentiviral overexpression of mutant huntingtin in rat striatum.
Régulier E; Trottier Y; Perrin V; Aebischer P; Déglon N
Hum Mol Genet; 2003 Nov; 12(21):2827-36. PubMed ID: 12952868
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotection by Hsp104 and Hsp27 in lentiviral-based rat models of Huntington's disease.
Perrin V; Régulier E; Abbas-Terki T; Hassig R; Brouillet E; Aebischer P; Luthi-Carter R; Déglon N
Mol Ther; 2007 May; 15(5):903-11. PubMed ID: 17375066
[TBL] [Abstract][Full Text] [Related]
6. Implication of the JNK pathway in a rat model of Huntington's disease.
Perrin V; Dufour N; Raoul C; Hassig R; Brouillet E; Aebischer P; Luthi-Carter R; Déglon N
Exp Neurol; 2009 Jan; 215(1):191-200. PubMed ID: 19022249
[TBL] [Abstract][Full Text] [Related]
7. Dysregulation of gene expression in primary neuron models of Huntington's disease shows that polyglutamine-related effects on the striatal transcriptome may not be dependent on brain circuitry.
Runne H; Régulier E; Kuhn A; Zala D; Gokce O; Perrin V; Sick B; Aebischer P; Déglon N; Luthi-Carter R
J Neurosci; 2008 Sep; 28(39):9723-31. PubMed ID: 18815258
[TBL] [Abstract][Full Text] [Related]
8. Progressive phenotype and nuclear accumulation of an amino-terminal cleavage fragment in a transgenic mouse model with inducible expression of full-length mutant huntingtin.
Tanaka Y; Igarashi S; Nakamura M; Gafni J; Torcassi C; Schilling G; Crippen D; Wood JD; Sawa A; Jenkins NA; Copeland NG; Borchelt DR; Ross CA; Ellerby LM
Neurobiol Dis; 2006 Feb; 21(2):381-91. PubMed ID: 16150600
[TBL] [Abstract][Full Text] [Related]
9. Experimental mutagenesis of huntingtin to map cleavage sites: different outcomes in cell and mouse models.
Tebbenkamp AT; Xu G; Siemienski ZB; Janus C; Fromholt SE; Brown HH; Swing D; Tessarollo L; Borchelt DR
J Huntingtons Dis; 2014; 3(1):73-86. PubMed ID: 25062766
[TBL] [Abstract][Full Text] [Related]
10. Dopamine enhances motor and neuropathological consequences of polyglutamine expanded huntingtin.
Cyr M; Sotnikova TD; Gainetdinov RR; Caron MG
FASEB J; 2006 Dec; 20(14):2541-3. PubMed ID: 17065224
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus vector-based in vitro neuronal cell model for Huntington's disease with human disease-like differential aggregation and degeneration.
Dong X; Zong S; Witting A; Lindenberg KS; Kochanek S; Huang B
J Gene Med; 2012 Jul; 14(7):468-81. PubMed ID: 22700462
[TBL] [Abstract][Full Text] [Related]
12. Unraveling a role for dopamine in Huntington's disease: the dual role of reactive oxygen species and D2 receptor stimulation.
Charvin D; Vanhoutte P; Pagès C; Borrelli E; Caboche J
Proc Natl Acad Sci U S A; 2005 Aug; 102(34):12218-23. PubMed ID: 16103364
[TBL] [Abstract][Full Text] [Related]
13. Transplantation of human embryonic stem cells alleviates motor dysfunction in AAV2-Htt171-82Q transfected rat model of Huntington's disease.
Islam J; So KH; Kc E; Moon HC; Kim A; Hyun SH; Kim S; Park YS
Stem Cell Res Ther; 2021 Nov; 12(1):585. PubMed ID: 34809707
[TBL] [Abstract][Full Text] [Related]
14. Antisense oligonucleotide-mediated correction of transcriptional dysregulation is correlated with behavioral benefits in the YAC128 mouse model of Huntington's disease.
Stanek LM; Yang W; Angus S; Sardi PS; Hayden MR; Hung GH; Bennett CF; Cheng SH; Shihabuddin LS
J Huntingtons Dis; 2013; 2(2):217-28. PubMed ID: 25063516
[TBL] [Abstract][Full Text] [Related]
15. IRE1 plays an essential role in ER stress-mediated aggregation of mutant huntingtin via the inhibition of autophagy flux.
Lee H; Noh JY; Oh Y; Kim Y; Chang JW; Chung CW; Lee ST; Kim M; Ryu H; Jung YK
Hum Mol Genet; 2012 Jan; 21(1):101-14. PubMed ID: 21954231
[TBL] [Abstract][Full Text] [Related]
16. Characterization of huntingtin pathologic fragments in human Huntington disease, transgenic mice, and cell models.
Schilling G; Klevytska A; Tebbenkamp AT; Juenemann K; Cooper J; Gonzales V; Slunt H; Poirer M; Ross CA; Borchelt DR
J Neuropathol Exp Neurol; 2007 Apr; 66(4):313-20. PubMed ID: 17413322
[TBL] [Abstract][Full Text] [Related]
17. Sustained effects of nonallele-specific Huntingtin silencing.
Drouet V; Perrin V; Hassig R; Dufour N; Auregan G; Alves S; Bonvento G; Brouillet E; Luthi-Carter R; Hantraye P; Déglon N
Ann Neurol; 2009 Mar; 65(3):276-85. PubMed ID: 19334076
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of apoptosis signal-regulating kinase 1 reduces endoplasmic reticulum stress and nuclear huntingtin fragments in a mouse model of Huntington disease.
Cho KJ; Lee BI; Cheon SY; Kim HW; Kim HJ; Kim GW
Neuroscience; 2009 Nov; 163(4):1128-34. PubMed ID: 19646509
[TBL] [Abstract][Full Text] [Related]
19. Intrastriatal CERE-120 (AAV-Neurturin) protects striatal and cortical neurons and delays motor deficits in a transgenic mouse model of Huntington's disease.
Ramaswamy S; McBride JL; Han I; Berry-Kravis EM; Zhou L; Herzog CD; Gasmi M; Bartus RT; Kordower JH
Neurobiol Dis; 2009 Apr; 34(1):40-50. PubMed ID: 19150499
[TBL] [Abstract][Full Text] [Related]
20. Modulation of nucleosome dynamics in Huntington's disease.
Stack EC; Del Signore SJ; Luthi-Carter R; Soh BY; Goldstein DR; Matson S; Goodrich S; Markey AL; Cormier K; Hagerty SW; Smith K; Ryu H; Ferrante RJ
Hum Mol Genet; 2007 May; 16(10):1164-75. PubMed ID: 17403718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
